BCR and neoplasm: As our previous studies qualitatively defined PSCA as a potential PC biomarker after radical prostatectomy, we conducted this study to definitively quantify the clinical usefulness of PSCA titer in blood samples by more accurately defining the PSCA/GAPDH ratio as a significant prognostic tumor biomarker for BCR.